Ifp Advisors, Inc Agios Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$29.58 - $49.78 $857 - $1,443	-29 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$34.45 - $53.48 $999 - $1,550	29 New	29 $2,000
Q1 2020 May 12, 2020	BUY	$31.52 - $53.81 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$30.08 - $50.59 $541 - $910	-18 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$32.4 - $49.58 $583 - $892	18 New	18 $1,000
Q3 2018 Oct 25, 2018	SELL	$71.67 - $91.95 $3,726 - $4,781	-52 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$73.22 - $99.55 $878 - $1,194	12 Added 30.0%	52 $0
Q1 2018 May 09, 2018	SELL	$59.83 - $86.53 $11,068 - $16,008	-185 Reduced 82.22%	40 $0
Q2 2016 Jun 03, 2019	BUY	N/A	225	225 $9,000

231

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.85B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.